StockData
Treace Medical Concepts, Inc. logo

Treace Medical Concepts, Inc. (TMCI) stock

TMCINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/3031% below fair value
$4.42−0.85 (-16.13%)

Close on Nov 16, 2026Market cap $287.45MP/E –Yield –

Treace Medical Concepts gross margin

Gross margin is gross profit as a percentage of revenue.

Treace Medical Concepts's gross margin for the twelve months ending Jun 30, 2026 was 79.5%. For fiscal 2025 it was 79.8%, against 80.4% the year before. The highest annual figure on record is 82.1% in fiscal 2021.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202579.8%−0.6
FY2024Dec 31, 202480.4%−0.8
FY2023Dec 31, 202381.2%−0.8
FY2022Dec 31, 202282.0%−0.1
FY2021Dec 31, 202182.1%+3.9
FY2020Dec 31, 202078.3%−2.4
FY2019Dec 31, 201980.6%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202678.5%−1.2
Q1 FY2026Mar 31, 202679.3%−0.4
Q4 FY2025Dec 31, 202580.6%−0.1
Q3 FY2025Sep 30, 202579.1%−1.1
Q2 FY2025Jun 30, 202579.7%−0.6
Q1 FY2025Mar 31, 202579.7%−0.5
Q4 FY2024Dec 31, 202480.7%−0.8
Q3 FY2024Sep 30, 202480.1%−0.2
Q2 FY2024Jun 30, 202480.2%−1.5
Q1 FY2024Mar 31, 202480.2%−0.8
Q4 FY2023Dec 31, 202381.6%−0.3
Q3 FY2023Sep 30, 202380.4%−1.2
Q2 FY2023Jun 30, 202381.7%−0.6
Q1 FY2023Mar 31, 202380.9%−1.4
Q4 FY2022Dec 31, 202281.9%−2.1
Q3 FY2022Sep 30, 202281.6%+1.2
Q2 FY2022Jun 30, 202282.3%+1.4
Q1 FY2022Mar 31, 202282.3%+0.1
Q4 FY2021Dec 31, 202183.9%+5.0
Q3 FY2021Sep 30, 202180.4%+0.8
Q2 FY2021Jun 30, 202180.9%+7.8
Q1 FY2021Mar 31, 202182.2%+3.4
Q4 FY2020Dec 31, 202078.9%–
Q3 FY2020Sep 30, 202079.6%–
Q2 FY2020Jun 30, 202073.1%–
Q1 FY2020Mar 31, 202078.8%–

More Treace Medical Concepts figures

See a number that looks wrong?